A MULTICENTER PHASE I-II STUDY OF TOSEDOSTAT IN THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA

被引：0
|
作者：
Ossenkoppele, G. [1 ]
Hooftman, W. [2 ]
Zweegman, S. [1 ]
Davies, E. [3 ]
Morgan, G. [3 ]
Mueller-Tidow, C. [4 ]
Krug, U. [4 ]
Duhrsen, U. [4 ]
Burnett, A. [5 ]
Jenkins, C. [5 ]
Zachee, P. [6 ]
Dierickx, D. [4 ]
Lowenberg, B. [7 ]
Sonneveld, P. [7 ]
Hooftman, L. [2 ]
Richardson, A. [2 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[2] Chroma Therapeut Ltd, Oxford, England
[3] Royal Marsden Hosp, London SW3 6JJ, England
[4] Univ Hosp, Munster, Germany
[5] Cardiff Univ Hosp, Cardiff, S Glam, Wales
[6] ZNA, Antwerp, Belgium
[7] Erasmus MC, Rotterdam, Netherlands
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1065
引用
收藏
页码：429 / 429
页数：1
相关论文
共 50 条
  • [21] Pevonedistat plus belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome: A phase I multicenter study
    Maher, Keri Renee
    Schafer, Danielle
    Schaar, Dale
    Sabo, Roy
    Bandyopadhyay, Dipankar
    Grant, Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] Single agent thalidomide in patients with relapsed or refractory acute myeloid leukaemia
    Thomas, DA
    Estey, E
    Giles, FJ
    Faderl, S
    Cortes, J
    Keating, M
    O'Brien, S
    Albitar, M
    Kantarjian, H
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 123 (03) : 436 - 441
  • [23] Phase I-II trial of oral cyclophosphamide, prednisone and lenalidomide for the treatment of patients with relapsed and refractory multiple myeloma
    Reece, Donna E.
    Masih-Khan, Esther
    Atenafu, Eshetu G.
    Jimenez-Zepeda, Victor H.
    Anglin, Peter
    Chen, Christine
    Kukreti, Vishal
    Mikhael, Joseph R.
    Trudel, Suzanne
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (01) : 46 - 54
  • [24] A PHASE I-II TRIAL OF 4'-DEOXYDOXORUBICIN (ESORUBICIN) IN REFRACTORY OR RELAPSED ACUTE-LEUKEMIA
    DUTCHER, JP
    RIGGS, CE
    STRAUMAN, JJ
    LINK, B
    WIERNIK, PH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (04) : 424 - 428
  • [25] A Phase I Study of Carfilzomib for Relapsed or Refractory Acute Myeloid and Acute Lymphoblastic Leukemia
    Wartman, Lukas D.
    Fiala, Mark A.
    Hawkins, Emily
    Fletcher, Theresa
    Allen, Melissa
    Cashen, Amanda F.
    DiPersio, John F.
    Jacoby, Meagan
    Stockerl-Goldstein, Keith E.
    Pusic, Iskra
    Uy, Geoffrey L.
    Westervelt, Peter
    Vij, Ravi
    BLOOD, 2014, 124 (21)
  • [26] A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia
    Wartman, Lukas D.
    Fiala, Mark A.
    Fletcher, Theresa
    Hawkins, Emily R.
    Cashen, Amanda
    DiPersio, John F.
    Jacoby, Meagan A.
    Stockerl-Goldstein, Keith E.
    Pusic, Iskra
    Uy, Geoffrey L.
    Westervelt, Peter
    Vij, Ravi
    LEUKEMIA & LYMPHOMA, 2016, 57 (03) : 728 - 730
  • [27] Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS
    Mawad, Raya
    Becker, Pamela S.
    Hendrie, Paul
    Scott, Bart
    Wood, Brent L.
    Dean, Carol
    Sandhu, Vicky
    Deeg, Hans Joachim
    Walter, Roland
    Wang, Lixia
    Myint, Han
    Singer, Jack W.
    Estey, Elihu
    Pagel, John M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 172 (02) : 238 - 245
  • [28] Treatment of Relapsed Acute Myeloid Leukaemia
    Kell, Jonathan
    REVIEWS ON RECENT CLINICAL TRIALS, 2006, 1 (02) : 103 - 111
  • [29] A Phase I Study of Lenalidomide and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
    Griffiths, Elizabeth A.
    Brady, William
    Tan, Wei
    Vigil, Carlos E.
    Thompson, James E.
    Ford, Laurie A.
    Dickey, Noelle M.
    Sperrazza, Jill
    Wang, Eunice S.
    Wetzler, Meir
    BLOOD, 2014, 124 (21)
  • [30] Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I-II GIMEMA trial
    Mauro, Francesca R.
    Carella, Angelo M.
    Molica, Stefano
    Paoloni, Francesca
    Liberati, Anna M.
    Zaja, Francesco
    Belsito, Valeria
    Cortellezzi, Agostino
    Rizzi, Rita
    Tosi, Patrizia
    Spriano, Mauro
    Ferretti, Antonietta
    Nanni, Mauro
    Marinelli, Marilisa
    De Propris, Maria S.
    Orlando, Sonia M.
    Vignetti, Marco
    Cuneo, Antonio
    Guarini, Anna R.
    Foa, Robin
    LEUKEMIA & LYMPHOMA, 2017, 58 (07) : 1640 - 1647
12345